NEUGEBOREN EDWARD 4
4 · Grace Therapeutics, Inc. · Filed May 13, 2025
Insider Transaction Report
Form 4
NEUGEBOREN EDWARD
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-05-09+10,000→ 10,000 totalExercise: $2.72Exp: 2035-05-09→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]50% of this option vests on the date of grant and the remaining 50% vests in substantially equal monthly installments on the 30th day of each month until September 30, 2025, subject to the Reporting Person's continuous service as of each vesting date.